A comparative bear model for immobility-induced osteopenia
P E Milbury1, M R Vaughan, S Farley
1Long Range Research Department, ESA, Inc., Chelmsford, MA 01824-4171, USA. tollers@tiac.net
Ursus (International Association for Bear Research and Management)
|May 15, 2003
Summary
Bears may hold the key to preventing bone loss during immobility. Researchers compared human and bear plasma, identifying unique compounds that could lead to new treatments for osteopenia.
Area of Science:
- Biochemistry
- Comparative Physiology
- Space Medicine
Background:
- Immobility-induced osteopenia is a significant health concern, particularly for astronauts and bedridden patients.
- Bears exhibit remarkable resistance to bone loss during winter dormancy, suggesting unique metabolic adaptations.
- Existing research has identified metabolic differences between ambulatory and immobile humans using advanced analytical techniques.
Purpose of the Study:
- To investigate the metabolic profiles of black bears across seasons and compare them with human metabolic data.
- To identify potential biomarkers or mechanisms responsible for preventing bone loss in dormant bears.
- To explore novel therapeutic strategies for immobility-induced osteopenia.
Main Methods:
- Creation of a comprehensive metabolic database comparing human ambulatory/bedrest plasma samples with seasonal bear plasma samples.
- Utilized high-performance liquid chromatography with coulometric electrochemical array detection (HPLC-EC) for compound analysis.
- Applied cluster analysis to identify significant metabolic differences between groups.
Main Results:
- Identified significant seasonal variations in 28 known and 33 unknown compounds in bear plasma.
- Established a primary dataset of 40 known and 120 unknown peaks for interspecies comparison.
- Discovered six unidentified compounds that exhibited differential changes in wintering bears and immobile humans.
Conclusions:
- Metabolic differences exist between dormant bears and immobile humans, offering potential insights into bone loss prevention.
- Specific unidentified compounds warrant further investigation for their role in mitigating osteopenia.
- This research could pave the way for new pharmaceutical or dietary interventions for immobility-related bone loss.
Related Concept Videos
01:40Bone Remodeling
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
01:29Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...